Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database.

ABSTRACT:

Background

The goal of this study is to evaluate the status and future perspectives of clinical trials on positron emission tomography in prostate cancer for diagnostic or therapeutic as well as for surveillance purposes.

Methods

The www.ClinicalTrials.gov database was searched on the 20th of January 2017 for all trials containing terms describing "prostate cancer" (prostate, prostatic, malignant, malignancy, cancer, tumor) and "positron emission tomography". In total 167 trials were identified. Trials that included diseases other than PCa were excluded (n = 27; 16%). Furthermore, we excluded trials (n = 4, 2%) withdrawn prior to first patient enrollment. The remaining trials (n = 137, 82%) were selected for further manual classification analysis.

Results

One hundred

SUBMITTER: Cihoric N 

PROVIDER: S-EPMC6006688 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature